The FDA specifically advises against using Zepbound in such cases: "ZEPBOUND is not recommended in patients with severe gastroparesis." FDA Prescribing Information Gastrointestinal side effects, particularly during the dose escalation phase, are common
Therefore, the intricate relationship between PCD-induced reproductive dysfunction and genetic, environmental, and lifestyle factors warrants further investigation
Practical clinical approach (Indian practice context) You may prescribe in GERD/hiatus hernia if: Symptoms are mild to moderate and controlled
Humectants are able to bind and hold large amounts of water to keep skin hydrated
What dose of Melanotan II do scientists use in animal models
Dual GLP-1/GCG agonists such as mazdutide and survodutide are currently in phase 3 clinical trials as obesity treatments, with pemvidutide having recently completed phase 2 trials